Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
143.6 USD | -0.50% | +10.20% | +21.94% |
Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.94% | 8.24B | |
+9.75% | 15.36B | |
-22.89% | 10.96B | |
-3.21% | 6.73B | |
+34.05% | 1.97B | |
+2.03% | 1.51B | |
+26.62% | 975M | |
+6.19% | 845M | |
+9.29% | 751M | |
-5.47% | 675M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection